Evolus (EOLS) Gross Margin (2019 - 2026)
Evolus (EOLS) posted Gross Margin of 65.02% for Q3 2026, down 1.45 percentage points from 66.47% a year earlier and down 2.98 percentage points from the prior quarter.
Evolus (EOLS) Gross Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Gross Margin at Evolus was 66.38%, down 0.25 percentage points year-over-year; for FY2025, it came in at 66.33%, down 2.14 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -1.31 percentage points (FY2020 to FY2025).
- In prior years, Evolus' Gross Margin was 68.46% in FY2024 (+0.39 pp), 68.08% in FY2023 (+7.67 pp), 60.41% in FY2022 (+4.08 pp) and 56.32% in FY2021 (-11.31 pp).
- The Q3 2026 figure stands as the lowest quarterly Gross Margin since Q4 2023.
- On a year-over-year basis, Gross Margin increased in two of the last eight quarters, with an average year-over-year change of -0.69 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2023, with a gain of 12.75 percentage points; the weakest was Q4 2021, with a drop of 10.32 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 68.00% (Q2 2026), 66.86% (Q1 2026) and 65.66% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Evolus | 455.33 Mn | 264.84 Mn | 50.69 Mn | 65.02% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 65.02% |
| Jun 30, 2026 | 68.00% |
| Mar 31, 2026 | 66.86% |
| Dec 31, 2025 | 65.66% |
| Sep 30, 2025 | 66.47% |
| Jun 30, 2025 | 65.31% |
| Mar 31, 2025 | 68.09% |
| Dec 31, 2024 | 66.67% |
| Sep 30, 2024 | 68.92% |
| Jun 30, 2024 | 70.35% |
| Mar 31, 2024 | 68.26% |
| Dec 31, 2023 | 63.56% |
| Sep 30, 2023 | 69.15% |
| Jun 30, 2023 | 70.19% |
| Mar 31, 2023 | 70.89% |
| Dec 31, 2022 | 62.60% |
| Sep 30, 2022 | 60.21% |
| Jun 30, 2022 | 57.43% |
| Mar 31, 2022 | 61.05% |
| Dec 31, 2021 | 54.31% |
Evolus Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();